GLP-1
Appetite Regulation
Semaglutide may reduce hunger and help patients feel full sooner, which can support smaller portions and a structured nutrition plan.
Florida Surgery And Weight Loss Center offers physician-supervised semaglutide care for adults across Florida through telehealth and in-office consultations in Hollywood. This guide explains the differences between Wegovy® and Ozempic®, what providers consider before prescribing, how insurance and self-pay access work, and what patients can expect during treatment.
The answer depends on your health history, current medications, treatment goals, and risk factors. A clinical assessment can clarify whether semaglutide or a different weight-management approach deserves consideration.
A provider reviews your medical history, BMI, current medications, previous treatment, weight-related conditions, goals, and relevant safety concerns. The visit is used to determine whether medication is appropriate and which next steps make clinical sense; it does not guarantee a prescription.
Semaglutide is a prescription medication that acts on the GLP-1 receptor. It may help regulate appetite, increase feelings of fullness, and slow gastric emptying. Medication is used as part of a broader treatment plan that may include nutrition, physical activity, behavioral support, and ongoing medical monitoring.
Semaglutide may reduce hunger and help patients feel full sooner, which can support smaller portions and a structured nutrition plan.
Each branded product follows its own instructions and escalation schedule. Patients should never transfer a dose or injection-unit calculation from one formulation to another.
Follow-up allows the provider to review response, tolerance, side effects, adherence, nutrition, and whether treatment changes are appropriate.
Wegovy® and Ozempic® both contain semaglutide, but they are separate FDA-approved products with different indications and prescribing information. They should not be described as interchangeable weight-loss medications.
| Medication | Active ingredient | Primary FDA-approved use | Coverage considerations |
|---|---|---|---|
| Wegovy® | Semaglutide | Chronic weight management for eligible patients; additional approved indications may apply. | Coverage varies by obesity benefits, clinical criteria, prior authorization, and pharmacy plan. |
| Ozempic® | Semaglutide | Type 2 diabetes and certain related risk-reduction indications. It is not approved specifically for weight loss. | Coverage commonly depends on diabetes-related criteria and the individual pharmacy benefit. |
Yes. Florida residents may complete an initial visit through secure telehealth when appropriate. Patients who prefer face-to-face care can schedule an appointment at the Hollywood clinic.
Choose a telehealth or in-office appointment and provide the requested intake information.
Review your health history, BMI, medications, goals, and potential safety concerns.
If treatment is appropriate, receive product-specific instructions, pharmacy coordination, and a clear next-step plan.
Monitor progress, tolerance, nutrition, and treatment needs with your medical provider.
Coverage varies. The answer depends on the product prescribed, its approved indication, your diagnosis, pharmacy benefits, deductible, prior authorization rules, and current availability. Medication, laboratory, and pharmacy charges are separate from the consultation fee.
Our team can help review available benefits and identify whether prior authorization or supporting documentation may be required. Coverage is not guaranteed.
If Wegovy® or Ozempic® is prescribed for an appropriate indication, the prescription is filled by a licensed pharmacy. Pharmacy pricing and coverage vary.
Patients without applicable coverage can discuss current self-pay pathways. Program availability and pricing are reviewed before treatment begins.
Weight change varies by starting weight, prescribed product, treatment duration, dose tolerance, medical conditions, nutrition, activity, sleep, and individual response. Early treatment often focuses on tolerability and gradual dose escalation rather than rapid weight loss.
Review realistic timelines and patient examples on our dedicated semaglutide before-and-after results page.
You can also explore the clinic’s broader medical and surgical weight-loss gallery.
Common adverse reactions associated with semaglutide products are primarily gastrointestinal. Your provider should explain product-specific risks, warnings, and what symptoms require medical attention.
Seek medical guidance for severe or persistent symptoms, signs of dehydration, significant abdominal pain, allergic reaction, vision changes, gallbladder symptoms, or other concerning changes.
Call 911 for a medical emergency.
Florida Surgery And Weight Loss Center is located at 1911 Harrison Street in Hollywood. Its statewide service area connects Florida residents with licensed medical providers without requiring travel to South Florida for every visit.
We serve patients in Hollywood, Miami, Fort Lauderdale, Hallandale Beach, Pembroke Pines, Aventura, Boca Raton, West Palm Beach, Orlando, Tampa, Jacksonville, Naples, Sarasota, Fort Myers, and surrounding Florida communities.
Have questions about your next step? Request an appointment to discuss your medical history, goals, and available treatment pathways.
Explore before-and-after transformations from patients who received bariatric surgery and physician-guided weight-loss care at Florida Surgery And Weight Loss Center. Every patient’s journey is unique, and individual results vary.
Individual results vary. Photographs reflect the experiences of individual patients and do not guarantee similar outcomes.